Overriding structures
|
disease |
|
Congenital Abnormality
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Inflammatory abdominal aortic aneurysm
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
MYOPATHY, MYOSIN STORAGE (disorder)
|
disease |
Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
7
|
15
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Idiopathic retroperitoneal fibrosis
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Chronic periaortitis
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
9
|
1
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Neurogenic Muscular Atrophy
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Pathologic Function
|
15
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Atrophy, Disuse
|
disease |
Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
16
|
|
0.030 |
None |
1.000 |
3 |
|
2012 |
2017 |
Dysferlinopathy
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
30
|
59
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
QRS complex feature
|
phenotype |
|
Finding
|
41
|
69
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Muscular Atrophy
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Pathologic Function
|
49
|
|
0.510 |
None |
1.000 |
3 |
|
2001 |
2010 |
Atrophic
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
58
|
1
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Alveolar Soft Part Sarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
61
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Varicella zoster
|
disease |
|
Disease or Syndrome
|
71
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Immunoglobulin G4-Related Disease
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
80
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cardiac Hypertrophy
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
88
|
11
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Myocardial Diseases, Secondary
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
101
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Cardiomyopathies, Primary
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
108
|
1
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Cancer cachexia
|
disease |
|
Neoplastic Process
|
110
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Childhood Leiomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
140
|
1
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Adult Leiomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
141
|
1
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Peripheral Vascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
150
|
18
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Malignant Fibrous Histiocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
150
|
3
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Muscle damage
|
phenotype |
|
Acquired Abnormality
|
163
|
4
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Sarcopenia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
164
|
10
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Osteoporosis, Postmenopausal
|
disease |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
171
|
38
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |